Diligence memo · auto-generated · as of July 2, 2026
Act Biotech Inc
Act Biotech Inc looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Act Biotech Inc operates in Biotechnology, based in SAN FRANCISCO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Act Biotech Inc has raised $2.5M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $1.0M on 2010-04-27.
Most recent recorded round closed around 2010-06-03.
Valuation (modeled)modeled
Provath models Act Biotech Inc at approximately $55M (range $533K–$626M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.82× the median modeled value of Pre-Seed Biotechnology companies in 2010–2012 (132 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 4 months.
Last raise 16.1 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 31% of Biotechnology peers (4293 compared).
Modeled value ranks above 48% of those peers.
Closest niche peers: Hygeia Therapeutics, Inc., Ikonopedia, LLC, Iquum Inc, Koronis Pharma, Inc., Olive Medical Corp.
Peoplefiled
7 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.